Copyright Reports & Markets. All rights reserved.

Global Nanotechnology for Healthcare Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Nanotechnology for Healthcare Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Nanotechnology for Healthcare Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Nanomedicine
    • 1.4.3 Nano Medical Devices
    • 1.4.4 Nano Diagnosis
    • 1.4.5 Other
  • 1.5 Market by Application
    • 1.5.1 Global Nanotechnology for Healthcare Market Share by Application: 2020 VS 2026
    • 1.5.2 Anticancer
    • 1.5.3 CNS Product
    • 1.5.4 Anti-infective
    • 1.5.5 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Nanotechnology for Healthcare Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Nanotechnology for Healthcare Industry
      • 1.6.1.1 Nanotechnology for Healthcare Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Nanotechnology for Healthcare Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Nanotechnology for Healthcare Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Nanotechnology for Healthcare Market Perspective (2015-2026)
  • 2.2 Nanotechnology for Healthcare Growth Trends by Regions
    • 2.2.1 Nanotechnology for Healthcare Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Nanotechnology for Healthcare Historic Market Share by Regions (2015-2020)
    • 2.2.3 Nanotechnology for Healthcare Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Nanotechnology for Healthcare Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Nanotechnology for Healthcare Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Nanotechnology for Healthcare Players by Market Size
    • 3.1.1 Global Top Nanotechnology for Healthcare Players by Revenue (2015-2020)
    • 3.1.2 Global Nanotechnology for Healthcare Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Nanotechnology for Healthcare Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Nanotechnology for Healthcare Market Concentration Ratio
    • 3.2.1 Global Nanotechnology for Healthcare Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Nanotechnology for Healthcare Revenue in 2019
  • 3.3 Nanotechnology for Healthcare Key Players Head office and Area Served
  • 3.4 Key Players Nanotechnology for Healthcare Product Solution and Service
  • 3.5 Date of Enter into Nanotechnology for Healthcare Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Nanotechnology for Healthcare Historic Market Size by Type (2015-2020)
  • 4.2 Global Nanotechnology for Healthcare Forecasted Market Size by Type (2021-2026)

5 Nanotechnology for Healthcare Breakdown Data by Application (2015-2026)

  • 5.1 Global Nanotechnology for Healthcare Market Size by Application (2015-2020)
  • 5.2 Global Nanotechnology for Healthcare Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Nanotechnology for Healthcare Market Size (2015-2020)
  • 6.2 Nanotechnology for Healthcare Key Players in North America (2019-2020)
  • 6.3 North America Nanotechnology for Healthcare Market Size by Type (2015-2020)
  • 6.4 North America Nanotechnology for Healthcare Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Nanotechnology for Healthcare Market Size (2015-2020)
  • 7.2 Nanotechnology for Healthcare Key Players in Europe (2019-2020)
  • 7.3 Europe Nanotechnology for Healthcare Market Size by Type (2015-2020)
  • 7.4 Europe Nanotechnology for Healthcare Market Size by Application (2015-2020)

8 China

  • 8.1 China Nanotechnology for Healthcare Market Size (2015-2020)
  • 8.2 Nanotechnology for Healthcare Key Players in China (2019-2020)
  • 8.3 China Nanotechnology for Healthcare Market Size by Type (2015-2020)
  • 8.4 China Nanotechnology for Healthcare Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Nanotechnology for Healthcare Market Size (2015-2020)
  • 9.2 Nanotechnology for Healthcare Key Players in Japan (2019-2020)
  • 9.3 Japan Nanotechnology for Healthcare Market Size by Type (2015-2020)
  • 9.4 Japan Nanotechnology for Healthcare Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Nanotechnology for Healthcare Market Size (2015-2020)
  • 10.2 Nanotechnology for Healthcare Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Nanotechnology for Healthcare Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Nanotechnology for Healthcare Market Size by Application (2015-2020)

11 India

  • 11.1 India Nanotechnology for Healthcare Market Size (2015-2020)
  • 11.2 Nanotechnology for Healthcare Key Players in India (2019-2020)
  • 11.3 India Nanotechnology for Healthcare Market Size by Type (2015-2020)
  • 11.4 India Nanotechnology for Healthcare Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Nanotechnology for Healthcare Market Size (2015-2020)
  • 12.2 Nanotechnology for Healthcare Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Nanotechnology for Healthcare Market Size by Type (2015-2020)
  • 12.4 Central & South America Nanotechnology for Healthcare Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Amgen
    • 13.1.1 Amgen Company Details
    • 13.1.2 Amgen Business Overview and Its Total Revenue
    • 13.1.3 Amgen Nanotechnology for Healthcare Introduction
    • 13.1.4 Amgen Revenue in Nanotechnology for Healthcare Business (2015-2020))
    • 13.1.5 Amgen Recent Development
  • 13.2 Teva Pharmaceuticals
    • 13.2.1 Teva Pharmaceuticals Company Details
    • 13.2.2 Teva Pharmaceuticals Business Overview and Its Total Revenue
    • 13.2.3 Teva Pharmaceuticals Nanotechnology for Healthcare Introduction
    • 13.2.4 Teva Pharmaceuticals Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.2.5 Teva Pharmaceuticals Recent Development
  • 13.3 Abbott
    • 13.3.1 Abbott Company Details
    • 13.3.2 Abbott Business Overview and Its Total Revenue
    • 13.3.3 Abbott Nanotechnology for Healthcare Introduction
    • 13.3.4 Abbott Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.3.5 Abbott Recent Development
  • 13.4 UCB
    • 13.4.1 UCB Company Details
    • 13.4.2 UCB Business Overview and Its Total Revenue
    • 13.4.3 UCB Nanotechnology for Healthcare Introduction
    • 13.4.4 UCB Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.4.5 UCB Recent Development
  • 13.5 Roche
    • 13.5.1 Roche Company Details
    • 13.5.2 Roche Business Overview and Its Total Revenue
    • 13.5.3 Roche Nanotechnology for Healthcare Introduction
    • 13.5.4 Roche Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.5.5 Roche Recent Development
  • 13.6 Celgene
    • 13.6.1 Celgene Company Details
    • 13.6.2 Celgene Business Overview and Its Total Revenue
    • 13.6.3 Celgene Nanotechnology for Healthcare Introduction
    • 13.6.4 Celgene Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.6.5 Celgene Recent Development
  • 13.7 Sanofi
    • 13.7.1 Sanofi Company Details
    • 13.7.2 Sanofi Business Overview and Its Total Revenue
    • 13.7.3 Sanofi Nanotechnology for Healthcare Introduction
    • 13.7.4 Sanofi Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.7.5 Sanofi Recent Development
  • 13.8 Merck & Co
    • 13.8.1 Merck & Co Company Details
    • 13.8.2 Merck & Co Business Overview and Its Total Revenue
    • 13.8.3 Merck & Co Nanotechnology for Healthcare Introduction
    • 13.8.4 Merck & Co Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.8.5 Merck & Co Recent Development
  • 13.9 Biogen
    • 13.9.1 Biogen Company Details
    • 13.9.2 Biogen Business Overview and Its Total Revenue
    • 13.9.3 Biogen Nanotechnology for Healthcare Introduction
    • 13.9.4 Biogen Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.9.5 Biogen Recent Development
  • 13.10 Stryker
    • 13.10.1 Stryker Company Details
    • 13.10.2 Stryker Business Overview and Its Total Revenue
    • 13.10.3 Stryker Nanotechnology for Healthcare Introduction
    • 13.10.4 Stryker Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 13.10.5 Stryker Recent Development
  • 13.11 Gilead Sciences
    • 10.11.1 Gilead Sciences Company Details
    • 10.11.2 Gilead Sciences Business Overview and Its Total Revenue
    • 10.11.3 Gilead Sciences Nanotechnology for Healthcare Introduction
    • 10.11.4 Gilead Sciences Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.11.5 Gilead Sciences Recent Development
  • 13.12 Pfizer
    • 10.12.1 Pfizer Company Details
    • 10.12.2 Pfizer Business Overview and Its Total Revenue
    • 10.12.3 Pfizer Nanotechnology for Healthcare Introduction
    • 10.12.4 Pfizer Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.12.5 Pfizer Recent Development
  • 13.13 3M Company
    • 10.13.1 3M Company Company Details
    • 10.13.2 3M Company Business Overview and Its Total Revenue
    • 10.13.3 3M Company Nanotechnology for Healthcare Introduction
    • 10.13.4 3M Company Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.13.5 3M Company Recent Development
  • 13.14 Johnson & Johnson
    • 10.14.1 Johnson & Johnson Company Details
    • 10.14.2 Johnson & Johnson Business Overview and Its Total Revenue
    • 10.14.3 Johnson & Johnson Nanotechnology for Healthcare Introduction
    • 10.14.4 Johnson & Johnson Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.14.5 Johnson & Johnson Recent Development
  • 13.15 Smith & Nephew
    • 10.15.1 Smith & Nephew Company Details
    • 10.15.2 Smith & Nephew Business Overview and Its Total Revenue
    • 10.15.3 Smith & Nephew Nanotechnology for Healthcare Introduction
    • 10.15.4 Smith & Nephew Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.15.5 Smith & Nephew Recent Development
  • 13.16 Leadiant Biosciences
    • 10.16.1 Leadiant Biosciences Company Details
    • 10.16.2 Leadiant Biosciences Business Overview and Its Total Revenue
    • 10.16.3 Leadiant Biosciences Nanotechnology for Healthcare Introduction
    • 10.16.4 Leadiant Biosciences Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.16.5 Leadiant Biosciences Recent Development
  • 13.17 Kyowa Hakko Kirin
    • 10.17.1 Kyowa Hakko Kirin Company Details
    • 10.17.2 Kyowa Hakko Kirin Business Overview and Its Total Revenue
    • 10.17.3 Kyowa Hakko Kirin Nanotechnology for Healthcare Introduction
    • 10.17.4 Kyowa Hakko Kirin Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.17.5 Kyowa Hakko Kirin Recent Development
  • 13.18 Shire
    • 10.18.1 Shire Company Details
    • 10.18.2 Shire Business Overview and Its Total Revenue
    • 10.18.3 Shire Nanotechnology for Healthcare Introduction
    • 10.18.4 Shire Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.18.5 Shire Recent Development
  • 13.19 Ipsen
    • 10.19.1 Ipsen Company Details
    • 10.19.2 Ipsen Business Overview and Its Total Revenue
    • 10.19.3 Ipsen Nanotechnology for Healthcare Introduction
    • 10.19.4 Ipsen Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.19.5 Ipsen Recent Development
  • 13.20 Endo International
    • 10.20.1 Endo International Company Details
    • 10.20.2 Endo International Business Overview and Its Total Revenue
    • 10.20.3 Endo International Nanotechnology for Healthcare Introduction
    • 10.20.4 Endo International Revenue in Nanotechnology for Healthcare Business (2015-2020)
    • 10.20.5 Endo International Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Nanotechnology for Healthcare status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nanotechnology for Healthcare development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    Amgen
    Teva Pharmaceuticals
    Abbott
    UCB
    Roche
    Celgene
    Sanofi
    Merck & Co
    Biogen
    Stryker
    Gilead Sciences
    Pfizer
    3M Company
    Johnson & Johnson
    Smith & Nephew
    Leadiant Biosciences
    Kyowa Hakko Kirin
    Shire
    Ipsen
    Endo International

    Market segment by Type, the product can be split into
    Nanomedicine
    Nano Medical Devices
    Nano Diagnosis
    Other
    Market segment by Application, split into
    Anticancer
    CNS Product
    Anti-infective
    Other

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Nanotechnology for Healthcare status, future forecast, growth opportunity, key market and key players.
    To present the Nanotechnology for Healthcare development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Nanotechnology for Healthcare are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now